IP Library Assignment 025768/0541
Patent Assignment
Reel/Frame 025768/0541

Assignment of Assignor's Interest

Recorded: 2011-02-02 Pages: 3
Assignor
COHEN, DAVID I.
Executed: 2010-12-08
Assignee
NANIRX, INC.
3960 BROADWAY #206, NEW YORK, NEW YORK, 10032
Covered Property (1)
Treatment of Cancers with Immunostimulatory HIV TAT Derivative Polypeptides
Patent: 8,530,431 →
Application: 12/730,043 →
Publication: US 2011/0009336
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Feb 23, 2011
From: NANIRX THERAPEUTICS, INC.
To: GBR INVESTMENTS, LLC; NGN BIOMED OPPORTUNITY I, L.P.; NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG; NEW YORK CITY INVESTMENT FUND, L.L.C.
Reel/Frame 025838/0876 →
Security Agreement Aug 1, 2011
From: NANIRX THERAPEUTICS, INC.
To: NGN BIOMED OPPORTUNITY I, L.P.; NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG; GBR INVESTMENTS, LLC; NEW YORK CITY INVESTMENT FUND, L.L.C.
Reel/Frame 026682/0684 →
Assignment of Assignor's Interest Dec 31, 2011
From: NANIRX THERAPEUTICS, INC.
To: PIN PHARMA, INC.
Reel/Frame 027467/0136 →